Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

1800-272-662
Shopping Cart 0
countryflagAU
Login

Home CompaniesOpyl Ltd

Opyl Ltd

Healthcare Health Information Services
PortfolioPortfolio WatchlistWatchlist
Company price
0.023 AUD 0.00(0%)
Last update at 2025-09-25T00:00:00Z
VOLUME
780665
Market Cap
6.51M

Momentum Score

…

Pathkey.AI Ltd engages in the development of digital tools that enhance healthcare experience for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs for pharmaceuticals, medical devices, alternative therapies, and novel conditions. It also provides TrialGen, an AI-powered tool streamlines clinical trial design process for biopharma, MedTech, government, and healthcare organizations. The company was formerly known as Opyl Limited and changed its name to Pathkey.AI Ltd in August 2025. Pathkey.AI Ltd was incorporated in 1994 and is based in Milsons Point, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.02
Low
0.02
High
52 Week Price Range
0.01
Low
0.04
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
0.02
Dividend Yield
-
Revenue TTM
0.20M
Revenue Per Share
0.00
Gross Profit TTM
-1.28M
Debt / Equity
-0.74
ROE
-248.28%
Net Debt
-0.37M
ROCE
1915.39%
Diluted EPS TTM
-0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -1.73M -2.09M -1.14M -0.88M -3.11M
Net income -1.73M -2.09M -1.63M -0.93M -4.97M
Selling general administrative 2.59M 2.59M 2.04M 1.68M 2.74M
Gross profit 0.61M 0.88M 0.76M 0.59M 0.93M
Reconciled depreciation 0.03M 0.03M 0.00M 0.00M 0.03M
Ebit -1.72M -2.08M -1.14M -0.86M -1.23M
Ebitda -1.70M -2.06M -1.14M -0.86M -1.21M
Depreciation and amortization 0.03M 0.03M 0.00M 0.00M 0.03M
Operating income -1.72M -2.08M -1.14M -0.86M -1.23M
Other operating expenses 2.95M 3.35M 2.38M 1.78M 3.18M
Interest expense 0.00M 0.00M 0.00M 0.03M 0.01M
Tax provision 0.00M 0.00M 0.00M 0.04M 0.00M
Interest income 0.00M 0.00M 0.00M 0.03M 0.01M
Net interest income -0.00M -0.00M -0.00M -0.03M -0.00M
Income tax expense 0.61M 0.00M 0.49M 0.04M 1.86M
Total revenue 0.61M 0.88M 0.76M 0.59M 0.93M
Total operating expenses 2.95M 3.35M 2.38M 1.78M 3.18M
Total other income expense net 0.61M -0.00M -0.00M -0.03M -1.87M
Net income from continuing ops -1.73M -2.09M -1.14M -0.93M -3.11M
Net income applicable to common shares -1.73M -2.09M -1.14M -0.93M -3.11M
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 0.41M 0.71M 0.98M 2.50M 0.94M
Intangible assets - 0.02M 0.04M 0.06M 0.06M
Other current assets 0.01M - 0.01M 0.01M 0.01M
Total liab 0.50M 1.11M 0.71M 0.31M 0.22M
Total stockholder equity -0.09M -0.40M 0.27M 2.19M 0.72M
Other current liab 0.26M 0.03M 0.50M 0.24M 0.16M
Common stock 22.50M 19.92M 19.27M 19.27M 16.84M
Capital stock - 19.92M 19.27M 19.27M 16.84M
Retained earnings -23.73M -20.97M -19.37M -17.41M -17.00M
Other liab - 0.01M 0.03M 0.03M -
Cash 0.37M 0.45M 0.79M 2.32M 0.80M
Cash and equivalents - 0.45M 0.79M 2.32M 0.80M
Total current liabilities 0.50M 1.10M 0.68M 0.29M 0.22M
Current deferred revenue - 0.58M - - -
Net debt -0.37M -0.15M -0.79M -2.32M -0.80M
Short term debt - 0.30M 0.00M 0.00M 0.00M
Short long term debt - 0.30M - - -
Short long term debt total - 0.30M - - -
Other stockholder equity - 0.64M 0.37M 0.33M 0.89M
Property plant equipment - 0.01M 0.02M 0.02M 0.01M
Total current assets 0.39M 0.67M 0.92M 2.43M 0.87M
Net tangible assets - -0.43M 0.23M 2.13M 0.66M
Net receivables 0.01M 0.22M 0.12M 0.10M 0.06M
Accounts payable 0.24M 0.19M 0.17M 0.05M 0.06M
Accumulated other comprehensive income 1.14M 0.64M 0.37M 0.33M 0.89M
Common stock total equity - - - - 16.84M
Non currrent assets other 0.01M - - - -
Non current assets total 0.02M 0.04M 0.06M 0.08M 0.07M
Long term debt total - 0.00M 0.00M 0.00M 0.00M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -0.00M -0.01M -0.01M -0.07M -0.69M
Change to liabilities 0.07M 0.40M 0.10M -0.31M -0.10M
Total cashflows from investing activities -0.00M -0.01M -0.01M -0.07M -0.69M
Net borrowings 0.15M 0.15M 0.15M -0.10M 0.20M
Total cash from financing activities 1.03M 1.03M 2.43M 1.81M 1.35M
Change to operating activities 0.01M 0.00M -0.00M 0.04M 0.09M
Net income -1.73M -2.09M -1.14M -0.93M -3.11M
Change in cash -0.33M -1.53M 1.52M 0.70M -1.45M
Begin period cash flow 0.79M 2.32M 0.80M 0.10M 1.55M
End period cash flow 0.45M 0.79M 2.32M 0.80M 0.10M
Total cash from operating activities -1.36M -2.06M -0.90M -1.03M -2.10M
Issuance of capital stock 0.96M - 2.68M 2.02M 1.22M
Depreciation 0.03M 0.03M 0.00M 0.00M 0.03M
Other cashflows from investing activities - - - 0.00M -0.69M
Change to account receivables 0.08M -0.03M -0.04M 0.12M 0.01M
Sale purchase of stock -0.07M 0.00M -0.25M -0.11M -0.07M
Other cashflows from financing activities 0.15M -0.01M -0.01M -0.07M 0.20M
Change to netincome 0.18M 0.16M 0.18M 0.05M 0.98M
Capital expenditures 0.00M 0.01M 0.01M 0.07M 0.01M
Change in working capital 0.61M 0.36M 0.47M 0.30M 0.01M
Other non cash items - 2.06M 1.14M 0.92M 3.08M
Free cash flow -0.00M -2.07M -0.01M -1.10M -2.10M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
OPL
Opyl Ltd		 -
-%		 0.02 - - 33.22 133.28 249.72 -0.68
PME
Pro Medicus Ltd		 -4.52
2.18%		 202.79 81.98 106.38 83.13 43.70 74.38 95.34
4DX
4DMEDICAL Ltd		 -0.06
2.53%		 2.31 - - 205.57 8.53 170.03 -7.29
CGS
Cogstate Ltd		 0.12
3.30%		 3.76 33.80 27.86 9.59 6.95 6.35 19.27
AYA
ARTRYA Ltd		 -0.14
3.91%		 3.44 - - 20505.14 7.00 16927.51 0.33

Profile*

Opyl Ltd

Pathkey.AI Ltd engages in the development of digital tools that enhance healthcare experience for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs for pharmaceuticals, medical devices, alternative therapies, and novel conditions. It also provides TrialGen, an AI-powered tool streamlines clinical trial design process for biopharma, MedTech, government, and healthcare organizations. The company was formerly known as Opyl Limited and changed its name to Pathkey.AI Ltd in August 2025. Pathkey.AI Ltd was incorporated in 1994 and is based in Milsons Point, Australia.

6 Middlemiss Street, Milsons Point, NSW, Australia, 2061

61 3 9923 1222

https://www.opyl.ai

Name Title Year Born
Ms. Michelle Gallaher Chief Exec. Officer NA
Mr. Mark Ziirsen Non-executive Director & CFO 1963
Mr. Damon Rasheed Exec. Director NA
Dr. Julian John Chick BSc (Hons) Exec. Director 1969
Mr. Shane Lewis VP of Sales & Partnerships NA
Mr. Scott Sorochak Chief Revenue Officer NA
Mr. Jason Weaver Chief Product Officer & Advisor NA
Mr. David Lilja M.B.A. Company Sec. NA
Mr. Mark Ziirsen CFO & Executive Chairman 1963
Mr. Damon Rasheed CTO & Executive Director NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CU6
AUD 2.05
+23.49%
DMP
AUD 25.06
+12.93%
G6M
AUD 2.74
+10.93%
XRO
AUD 75.17
+6.08%
SGR
AUD 0.17
+6.06%
AXQ
AUD 3.07
-18.35%
BOE
AUD 1.50
-9.39%
GQG
AUD 0.71
-8.97%
MI6
AUD 0.81
-8.52%
ELV
AUD 3.73
-8.35%

Equity Sectors*

  • Basic Materials

    -3.09%

  • Communication Services

    +0.75%

  • Consumer Cyclical

    +0.43%

  • Consumer Defensive

    +0.12%

  • Energy

    -1.07%

  • Financial Services

    -0.02%

  • Healthcare

    +1.08%

  • Industrials

    -0.22%

  • Real Estate

    +0.61%

  • Technology

    -1.69%

  • Utilities

    -0.18%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…